Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales of the…
Douglas A. McIntyre Texas Instruments (TXN) Bad earnings take chip company down. Falls to $23.28 from 52-week high of $38.79. AMD (AMD) Chip company may have changed CEOs but Wall St. still thinks company is…
According to Reuters, Apple (AAPL) missed Wall St. expectations, sending the stock down by 10%. Reuters reports that American Express (AXP) profits fell on credit losses.
Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface. The problem is that the surface is about the only thing that looked appealing for the drug giant…
Douglas A. McIntyre These are not all of the upgrades or positive analyst calls seen this morning but these are some of the top calls seen this Friday morning: Aventine Renewable (NYSE: AVR) Raised to…
According to Reuters, Robert Steel was named the new CEO of Wachovia (WB) and the bank said it would have a quarter loss of $2.6 to $2.8 billion. Reuters writes that the…
We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site. The study showed that a combination of fish oil and red…
According to Reuters, Microsoft (MSFT) is willing to start buy-out talks with Yahoo! (YHOO) if the portal company will replace its board. Reuters writes that the CEO of JP Morgan (JPM) said…
These are ten of the analyst calls with upgrades and downgrades we are focusing on this Monday morning in pre-market trading: Acme Packet (NASDAQ: APKT) cut to Underweight at JPMorgan; cut to…
We saw another exciting week full of news for key developments in drug stocks, biotech stocks, medical device stocks, and other companies involved in various aspects of health care and medicine. Below…
It used to be that DEFENSIVE STOCKS were the way to go during periods of uncertainty and during times of market sell-offs. But now that isn’t even working out. After we looked…
Today’s 52-week low list was full of some of the usual suspects, and you can count airlines as the top group of 52-week lows after that breather in oil prices did not…
According to Reuters, Microsoft’s (MSFT) Steve Ballmber said his company will not bid for Yahoo! (YHOO). Reuters writes that HP’s (HPQ) operating margin rose to 10% in the last quarter. Reuters writes…
Shares of Amgen Inc. (NASDAQ: AMGN) are seeing a small gain in after-hours trading. The troubled biotech giant announced that findings from its head-to-head, double-blind trial comparing the effects of denosumab in…
Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China, Russia, Brazil,…